Website
Industry
Recent investment activity
KANDO id: 14396492
Corporate information
Official name
Athyrium Capital Management LP
Overview
Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium advises funds with over $4.6 billion in committed capital. The Athyrium team has substantial investment experience across a wide range of asset classes including public equity, private equity, fixed income, royalties, and other structured securities. Athyrium invests across all healthcare verticals including biopharma, medical devices and products, healthcare focused services, and healthcare information technology. The team partners with management teams to implement creative financing solutions to companies' capital needs.
Funding rounds
Actual initial investment stage
Debt (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
Calliditas Therapeutics AB | Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. | Debt Initial investment led the round |